This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2017-08-10 Patient Care FHIR Call"
Jump to navigation
Jump to search
| Line 206: | Line 206: | ||
=== Joint Discussion PC/OO/Pharmacy === | === Joint Discussion PC/OO/Pharmacy === | ||
| − | |||
| − | |||
Questions raised about BiologicallyDerivedProduct (which can include blood products, tissues, organs) as well as procedures that are dosed (e.g. radiation-therapy & light therapy) | Questions raised about BiologicallyDerivedProduct (which can include blood products, tissues, organs) as well as procedures that are dosed (e.g. radiation-therapy & light therapy) | ||
| Line 226: | Line 224: | ||
| + | === WGM Planning === | ||
| + | Patient Care WGM agenda: [[PC_Sept_2017_WGM]] | ||
| + | <br> | ||
SOAP / ClinicalImpression | SOAP / ClinicalImpression | ||
* [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=12676 GF#12676] Guidance request for GP SOAP in FHIR (Alexander Henket) - | * [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=12676 GF#12676] Guidance request for GP SOAP in FHIR (Alexander Henket) - | ||
Revision as of 20:36, 10 August 2017
Contents
Meeting Information
| Patient Care FHIR Resources Conference Call Location: Conference Call |
Date: 2017-08-10 Time: 5-6:30pm ET | ||
| Facilitator | Michelle M Miller | Note taker(s) | Michelle M Miller |
| Attendee | Name | Affiliation
| |
| Elaine Ayres | NIH/Department of Clinical Research Informatics | ||
| Dave Carlson | VA | ||
| Stephen Chu | The Australian Digital Health Agency (ADHA) | ||
| Evelyn Gallego | EMI Advisors LLC | ||
| Eric Haas | Haas Consulting | ||
| Rob Hausam | Hausam Consulting LLC | ||
| Laura Heermann-Langford | Intermountain Healthcare | ||
| Emma Jones | Allscripts | ||
| Russ Leftwich | InterSystems | ||
| Tony Little | Optum 360 | ||
| Jay Lyle | Ockham Information Services LLC, VA | ||
| Russell McDonell | Telstra Health | ||
| Lloyd McKenzie | Gevity (HL7 Canada) | ||
| Larry McKnight | Cerner | ||
| Michelle M Miller | Cerner | ||
| Lisa Nelson | Life Over Time Solutions | ||
| Viet Nguyen | Lockheed Martin, Systems Made Simple | ||
| M'Lynda Owens | Cognosante | ||
| Mike Padula | The Children's Hospital of Philadelphia | ||
| Craig Parker | Intermountain Healthcare | ||
| Joe Quinn | Optum | ||
| Simon Sum | Academy of Nutrition and Dietetics | ||
| Iona Thraen | Dept of Veterans Affairs | ||
| Serafina Versaggi | Dept of Veterans Affairs | ||
| Buitendijk,Hans | Cerner | ||
| JD Nolen | |||
| Kenneth McCaslin | Accenture | ||
| Lorraine Constable | |||
| Patrick Loyd | |||
| Riki Merrick | |||
| Melva Peters | Gevity | ||
| John Hatem | |||
| Jean Duteau | |||
| Scott Robertson | |||
| Jose Costa Teixeira | |||
| Grahame Grieve | |||
| Quorum Requirements Met: yes | |||
Agenda
Agenda Topics
- Agenda review
- Approve previous meeting minutes 2017-08-03_Patient_Care_FHIR_Call
- Motion: <moved>/<seconded>
- OO/PC/Pharmacy Joint Discussion
Supporting Information
- Tracker Issues - https://docs.google.com/a/lmckenzie.com/uc?id=0B285oCHDUr09Mzh3b09rMFhEV1E
- Resolve QA Warnings to have resource FMM > 0
- Resolve QA Information messages to achieve FMM = 3
- Maintain QA checklist
Minutes
Joint Discussion PC/OO/Pharmacy
Questions raised about BiologicallyDerivedProduct (which can include blood products, tissues, organs) as well as procedures that are dosed (e.g. radiation-therapy & light therapy)
- GF#8458 Is a blood transfusion closer to a medication administration or a procedure, or something else?
- GF#12993 Please Create a NonMedicationAdministration object or an Administration object
- GF#12673 How to handle HCT/TP
- GF#13047 and GF#12966 Add DosageInstructions to Procedure/ProcedureRequest
- 2017-04-13_Patient_Care_FHIR_Call
- NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material
- It would include things like bone marrow, cord blood, peripheral blood stem cells - and any new resource could also address solid organs and blood transfusion although not part of the initial use case
- Align with scope of ISBT128, the purpose of which is: to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant. (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
- Per Feb 2016 OO ListServ, proposed boundaries included
- Device: a manufactured item that is used in the provision of healthcare without being substantially changed through that activity. The device may be a medical or non-medical device
- Substance: A homogeneous material with a definite composition
- BiologicallyDerivedProduct: material extracted from a living mammalian organism or that is still living
WGM Planning
Patient Care WGM agenda: PC_Sept_2017_WGM
SOAP / ClinicalImpression
- GF#12676 Guidance request for GP SOAP in FHIR (Alexander Henket) -
- https://chat.fhir.org/#narrow/stream/implementers/topic/ClinicalImpression
- PC, SD - possibly Thurs Q2
Adjourn
Adjourned at <hh:mm am/pm> <timezone>.
Meeting Outcomes
| Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2012 Health Level Seven® International. All rights reserved.
